Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:PFE

Pfizer Inc (PFE)

28.06
+0.09 (0.32%)
as of Aug 25, 2026, 2:11:02 pm Market Open.
582 watching
0
Investor Insights
star iconAug 25, 2026, 12:00 am

This summary was created by AI, based on 24 opinions in the last 12 months.

Pfizer Inc. (PFE) is facing significant challenges as it navigates a patent cliff following the success of its COVID-19 vaccine. Many experts are concerned about its ability to generate new blockbuster drugs and the sustainability of its high dividend yields, which currently range from 6.4% to 7%. Several reviews emphasize that while the dividend is attractive, the company lacks earnings momentum and has uncertainty surrounding its drug pipeline. The stock trades at low earnings multiples, suggesting it may be undervalued, but experts warn that the lack of growth drivers could limit upside potential. Overall, patience may be required for investors looking for signs of recovery or growth in the company's future, especially as its recent acquisitions are yet to yield significant results.

consensus icon
Consensus
Neutral
valuation icon
Valuation
Undervalued
review icon
Similar
MRK
BUY
In the midst of a large merger.
BUY
Extremely cheap. Great product line up.
WEAK BUY
Starting to look good at $26.
DON'T BUY
Great company. Could drop further.
BUY ON WEAKNESS
Good long term track record. Good management. Would like at a lower level.
BUY
Likes the drug sector.
BUY
Sector has been hit hard. At a good level. Prefers Pfizer over Merck.
DON'T BUY
DON'T BUY
Maney that went in as a defensive move is now leaving. Valuation in the sector got too high.
BUY
Excellent company. Should meet their growth potential this year. Great product lines.
WEAK BUY
Company has been doing well. Revenues growing @ 10%, earnings @ 20%. Trading at 19 X. Great long term.
DON'T BUY
Expensive.
TOP PICK
(Was a top pick on Mar 23 no change) A fan of pharmaceuticals and thinks this is the best. Goor R&D and sales.
DON'T BUY
Great com;pany. Valuation is too high.
STRONG BUY
Great product line/sales force. Good price.
Showing 811 to 825 of 887 entries